rhil-4 Search Results


100 ng/ml of rhil-4  (ImmunoTools)
90
ImmunoTools 100 ng/ml of rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
100 Ng/Ml Of Rhil 4, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pmc10820252-53-13-19?v=ImmunoTools
Average 90 stars, based on 1 article reviews
100 ng/ml of rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
recombinant human interleukin-4 rhil-4  (PeproTech)
90
PeproTech recombinant human interleukin-4 rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Recombinant Human Interleukin 4 Rhil 4, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/10__2147_slash_ott__s65367-25-8-15?v=PeproTech
Average 90 stars, based on 1 article reviews
recombinant human interleukin-4 rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4 at 1000 u/ml  (Schering-Plough corporation)
90
Schering-Plough corporation rhil-4 at 1000 u/ml
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4 At 1000 U/Ml, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pm12080377-149-9-18?v=Schering-Plough+corporation
Average 90 stars, based on 1 article reviews
rhil-4 at 1000 u/ml - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (Immunex Corporation)
90
Immunex Corporation rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by Immunex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pm11035105-49-30-34?v=Immunex+Corporation
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (Primmune Inc)
90
Primmune Inc rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by Primmune Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pm18350544-179-9-16?v=Primmune+Inc
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (Becton Dickinson)
90
Becton Dickinson rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pm17257215-31-8-13?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
25 ng/ml rhil-4 (interleukin 4)  (AbCys s a)
90
AbCys s a 25 ng/ml rhil-4 (interleukin 4)
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
25 Ng/Ml Rhil 4 (Interleukin 4), supplied by AbCys s a, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/10__3892_slash_ijo__31__6__1357-41-32-37?v=AbCys+s+a
Average 90 stars, based on 1 article reviews
25 ng/ml rhil-4 (interleukin 4) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil4  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc rhil4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil4, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pmc06911055-333-12-13?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
rhil4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (Nordic BioSite)
90
Nordic BioSite rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by Nordic BioSite, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pmc01906006-102-18-19?v=Nordic+BioSite
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (HumanZyme)
90
HumanZyme rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by HumanZyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pmc04197567-79-22-23?v=HumanZyme
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-12  (Strathmann Biotec AG)
90
Strathmann Biotec AG rhil-12
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 12, supplied by Strathmann Biotec AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pm18322218-53-30-31?v=Strathmann+Biotec+AG
Average 90 stars, based on 1 article reviews
rhil-12 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rhil-4  (FUJIFILM)
90
FUJIFILM rhil-4
Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation <t>cocktail</t> <t>(rhIL-4,</t> rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.
Rhil 4, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-4/pmc01941918-66-0-6?v=FUJIFILM
Average 90 stars, based on 1 article reviews
rhil-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation cocktail (rhIL-4, rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.

Journal: Life

Article Title: In Vitro Effects of Cypermethrin and Glyphosate on LPS-Induced Immune Cell Activation

doi: 10.3390/life14010062

Figure Lengend Snippet: Effects of Cypm (reported as C in the graph) on MBT-induced activation in naïve THP-1 and iDCs. ( A , B ) Naïve THP-1 cells (10 6 cells/mL) were treated for 24 h with Cypm (0.4 μg/mL) or with DMSO as vehicle, then stimulated with or without MBT (30 μg/mL) for 24 h. The expression of CD86 ( A ) and the release of IL-8 ( B ), as expressed as pg/mL, are reported. ( C – F ) iDCs (2 × 10 5 cells/mL) were treated for 72 h with Cypm (0.4 μg/mL) plus MBT (30 μg/mL), MBT alone, or with maturation cocktail (rhIL-4, rhGM-CSF, rhTNF-α, and ionomycin) (mDCs), as described in . The expression of CD83 + cells ( C ) and HLA-DR + cells ( D ) as expressed as fold-change (SI) were measured by FACS analysis, and the release of IL-6 ( E ) and IL-18 ( F ), expressed as pg/mL, was measured by ELISA. Each value represents the mean ± SEM, n = 3 independent experiments. Data were analyzed by paired t -test, with * p < 0.05 and ** p < 0.01.

Article Snippet: To obtain immature DCs (iDCs), THP-1 cells were differentiated with 100 ng/mL of rhIL-4 and 100 ng/mL of rhGM-CSF (ImmunoTools, Friesoythe, Germany) for 5 days.

Techniques: Activation Assay, Expressing, Enzyme-linked Immunosorbent Assay